Interrelationships between prostanoids and skin flap survival: a review.
Knight
K R
KR
Microsurgery Research Centre, St Vincent's Hospital, Melbourne, Australia.
Lepore
D A
DA
O'Brien
B M
BM
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004357:Drug Synergism; D011464:Epoprostenol / Q000494:pharmacology / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D007511:Ischemia / Q000188:drug therapy / Q000503:physiopathology; D008084:Lipoxygenase / Q000378:metabolism; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use; D009569:Nitric Oxide / Q000494:pharmacology; D011183:Postoperative Complications / Q000188:drug therapy*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000494:pharmacology / Q000627:therapeutic use*; D012867:Skin / Q000098:blood supply / Q000293:injuries; D016038:Skin Transplantation / Q000379:methods*; D013524:Surgical Flaps; D013927:Thrombosis / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use*
D016861:Cyclooxygenase Inhibitors; D005343:Fibrinolytic Agents; D016859:Lipoxygenase Inhibitors; D011453:Prostaglandins; D014665:Vasodilator Agents; D016718:Arachidonic Acid; D009569:Nitric Oxide; D011464:Epoprostenol; D008084:Lipoxygenase; D011451:Prostaglandin-Endoperoxide Synthases; D016285:Iloprost